ArticleBMC microbiology2025
Transcriptomic and metabolomic analysis of the antibacterial mechanism of sanguinarine against Enterobacter cloacae in vitro.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Research on the application of a high-throughput fully automated bacterial growth curve monitor for screening natural antibacterial compounds.BMC microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEnterobacter cloacae (E. cloacae) is a notorious pathogen that poses serious threat to both human and animal health, causing severe gut infections and contributing to food spoilage. Traditional chemical treatment have led to increased drug resistance and environmental pollution. This study investigates the potential of Sanguinarine (SAN), a natural plant extract, as an alternative to chemical antibiotics.
resultsIn light of the escalating issue of antibiotic resistance, we examined the antibacterial efficacy and mechanisms of SAN against E. cloacae in vitro. Our findings revealed a minimum inhibitory concentration (MIC) of 100 µg/mL for SAN. Scanning electron microscopy (SEM) demonstrated substantial morphological disruptions in E. cloacae cells treated with SAN. Concurrently, a significant increase in absorbance at 260 nm suggested nucleic acid leakage, indicative of compromised cell membrane integrity. Comprehensive transcriptomic and metabolomic analyses revealed that SAN primarily disrupts amino acid synthesis and energy metabolism pathway in E. cloacae.
conclusionsSAN exhibited potential antibacterial activity against E. cloacae, which can effectively inhibit its growth and disrupt its bacterial morphology and exert antibacterial effect through multiple pathways, and can be used as a potential substitute for antibiotics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.